发明名称 |
CD19-SPECIFIC RE-DIRECTED IMMUNE CELL |
摘要 |
PROBLEM TO BE SOLVED: To provide a genetically engineered re-directed immune cells and the cellular immunotherapy of B-cell-mediated autoimmune diseases.SOLUTION: This genetically engineered CD19-specific re-directed immune cells expressing a cell surface protein having an extracellular domain comprising a CD19-specific receptor, an intracellular signaling domain and a membrane-penetrating domain, the use of such the cells for the cellular immunotherapy of CD19malignant diseases and for abrogating untoward B-cell functions, and a method for preparing the re-directed T-cells expressing a chimera T-cell receptor by the electroporation using naked DNA encoding the receptor are provided. |
申请公布号 |
JP2011004749(A) |
申请公布日期 |
2011.01.13 |
申请号 |
JP20100167105 |
申请日期 |
2010.07.26 |
申请人 |
CITY OF HOPE |
发明人 |
JENSEN MICHAEL C;FORMAN STEPHEN;RAUBITSCHEK ANDREW |
分类号 |
C12N15/09;A61K35/12;A61K35/14;A61K35/28;A61K38/00;A61K38/20;A61K39/395;A61P35/00;A61P35/02;A61P37/02;A61P37/06;C07K14/705;C07K14/725;C07K16/28;C07K19/00;C12N5/0783;C12N5/10;C12N15/12;C12P21/08 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|